# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 614 results.
Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer
Status: Recruiting
Last Changed: Nov 19, 2019
First Received: Sep 13, 2019
Disease(s): Ovarian Cancer
Intervention(s): IMP4297
Locations: Xiaohua.Wu, Shanghai, China
Cost Utility of Radical Surgery in Ovarian Cancer
Status: Recruiting
Last Changed: Aug 08, 2019
First Received: Aug 03, 2016
Disease(s): Ovarian Cancer
Intervention(s): Collection of additional data with questionnaires
Locations: Institut de Cancerologie de L'Ouest, Angers, France
Institut Bergonie, Bordeaux, France
Chu Clermont Ferrand, Clermont Ferrand, France
Centre Jean Perrin, Clermont Ferrand, France
Centre Oscar Lambret, Lille, France
... and 10 other locations.
Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Dec 04, 2019
First Received: Mar 19, 2019
Disease(s): Ovarian Cancer
Intervention(s): HRD and BRCA mutations
Locations: Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, France
The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance
Status: Not yet recruiting
Last Changed: Apr 04, 2019
First Received: Feb 20, 2019
Disease(s): Ovarian Cancer
Intervention(s): Biopsy
Locations: Hillel Yaffe Medical Center, Hadera, Israel
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: May 08, 2019
First Received: May 08, 2019
Disease(s): Ovarian Cancer
Intervention(s): albumin-bound paclitaxel, Apatinib
A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Mar 29, 2019
First Received: Mar 29, 2019
Disease(s): Ovarian Cancer
Intervention(s): niraparib, Brivanib
Locations: Jing Wang, Changsha, Hunan, China
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Status: Not yet recruiting
Last Changed: Nov 26, 2019
First Received: Nov 20, 2019
Disease(s): Ovarian Cancer
Intervention(s): IMP4927, Placebos
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Status: Recruiting
Last Changed: Nov 04, 2019
First Received: Jun 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Manganese Chloride, nab-paclitaxel, Platinum chemotherapy, Sintilimab
Locations: Biotherapeutic Department of Chinese PLA General Hospital, Beijing, Beijing, China
A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients
Status: Not yet recruiting
Last Changed: Mar 05, 2019
First Received: Mar 05, 2019
Disease(s): Ovarian Cancer
Intervention(s): Fluzoparib capsules, Placebo capsules
Locations: Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Status: Not yet recruiting
Last Changed: Jun 06, 2018
First Received: Jun 06, 2018
Disease(s): Ovarian Cancer
Intervention(s): Apatinib